Dexamethasone 0.1% ophthalmic suspension

DRUG3 trials

Sponsors

Alcon Research, Azienda USL Reggio Emilia - IRCCS, Maastricht University Medical Center

Conditions

Allergic ConjunctivitisFuchs' Endothelial DystrophyInflammation EyeIntraocular PressurePseudophakic Bullous Keratopathy

Phase 4

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

CompletedNCT01119287

Alcon ResearchAllergic Conjunctivitis

Start: 2010-03-31End: 2010-09-30Updated: 2014-02-28

Bromfenac Versus Dexamethasone After Cataract Surgery

CompletedNCT03317847

Azienda USL Reggio Emilia - IRCCSInflammation Eye

Start: 2017-10-16End: 2019-12-21Updated: 2025-06-25

The OPTIMISE Study

RecruitingNCT05716945

Maastricht University Medical CenterFuchs' Endothelial Dystrophy, Intraocular Pressure, Pseudophakic Bullous Keratopathy

Start: 2024-07-29End: 2029-03-31Target: 342Updated: 2025-10-06

Related Papers

Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.

2020-05-2117 citations

Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.

2019-09-039 citations